Saudi Arabia Left Ventricular Assist Devices (LVADs) Market Report – 2025 Outlook, Trends, Share, Size & Forecast

MarkNtel Advisors has unveiled its latest research report on the Saudi Arabia Left Ventricular Assist Devices (LVADs) Market, providing an in-depth analysis of market dynamics, growth prospects, and competitive landscape. This report serves as a valuable resource for stakeholders aiming to capitalize on emerging opportunities and navigate potential challenges in the Saudi Arabia Left Ventricular Assist Devices (LVADs) industry.

Saudi Arabia Left Ventricular Assist Devices (LVADs) Market Size: 2025 Outlook

The Saudi Arabia Left Ventricular Assist Devices (LVADs) Market size was valued at around USD 21.92 million in 2024 and is projected to reach USD 42.29 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.81% during the forecast period, i.e., 2025-30. The Saudi Arabia Left Ventricular Assist Devices Market reports strong growth pushed via several key factors. One of these is the growing cases in Saudi Arabia of heart failure.

U.S. tariffs are changing—are you prepared? Download your free sample PDF of the report for timely data and expert advice – https://www.marknteladvisors.com/query/request-sample/saudi-arabia-lvads-market.html

📘 Scope of the Report

  • Forecasts till 2030 with year-wise market breakdown
  • Geographical and segment-level analysis
  • Company profiles and strategic insights
  • Key market drivers and restraints
  • Analysis of market trends and investment opportunities

What’s Driving the Market?

Increasing Prevalence of Cardiac Disorders & Heart Failure – With the rising prevalence of heart disorders like Arrhythmias, heart valve disease, cardiomyopathy, and heart failure, there is a high demand for left ventricular assist devices. As per Saudi Health Ministry data, in 2022, there were 45% deaths based on heart disorders in the kingdom. In Addition to this, around 15% of Saudi residents are encountering high blood pressure, which gets worsened by diabetes and obesity. With an estimated 70% of people being overweight in 2023, Saudi Arabia has one of the highest obesity rates in the world, according to the Saudi Food and Nutrition Association. The modifiable risk causes such as hypertension, type-2 diabetes, dyslipidemia, and sedentary lifestyle are behind CVD in the population of this country. The prevalence of dyslipidemia is 49.6% and hypertension is 32.1% as per a study conducted by Saudi Medical Journal,2023. The government is running various awareness programs like the National Campaign against Overweight and Obesity, run by the Saudi Government wherein individuals can contact the “Weight Program” of the Ministry of Health to design nutrition programs appropriate to their requirements and health conditions. Still, CVD cases are rising including disorders like Coronary heart disorder, cerebrovascular, peripheral arterial diseases, etc., and thus demand for LVAD is increasing since this is mandatorily required for the treatment of heart failure.

What’s Holding Back Growth?

High Health Risks Associated with LVADs and Procedures – Employing the devices and methods for their insertion will certainly subject the Saudi Arabian LVAD market to significant health hazards. The dangers associated with LVAD implantation are significant and encompass bleeding, infection, blood clots, and potential device malfunction. It is a highly intricate surgical operation. The consequences of these issues are significant enough to adversely affect both the patient's health and the healthcare system. In Saudi Arabia, these problems are exacerbated by patients and certain medical professionals who have a limited understanding of LVADs. Furthermore, post-implantation care requires ongoing check-ups and specialized expertise, which may often be lacking, especially in rural regions.

Access Full Market Insights & Key Statistics! https://www.marknteladvisors.com/research-library/saudi-arabia-lvads-market.html

Use your official business email to connect with our team and enjoy full access with priority support.

Saudi Arabia Left Ventricular Assist Devices (LVADs) Market Segmentation

By Type of Flow

  • Pulsatile Flow - Market Size & Forecast 2020-2030, USD Million
  • Non-Pulsatile Flow - Market Size & Forecast 2020-2030, USD Million

By Design

  • Implantable Ventricular Assist Devices - Market Size & Forecast 2020-2030, USD Million
  • Transcutaneous Ventricular Assist Devices - Market Size & Forecast 2020-2030, USD Million

By Application

  • Bridge to Transplantation - Market Size & Forecast 2020-2030, USD Million
  • Destination Therapy - Market Size & Forecast 2020-2030, USD Million
  • Bridge to Recovery - Market Size & Forecast 2020-2030, USD Million
  • Bridge to Candidacy - Market Size & Forecast 2020-2030, USD Million

By Region

  • West
  • East
  • North
  • South
  • Central

 

🏢 Industry Leaders: Who’s Dominating the Saudi Arabia Left Ventricular Assist Devices (LVADs) Market?

The market is highly competitive, with players launching innovation-driven products and investing in strategic partnerships. Key participants include:

  • Abbott Laboratories
  • Medtronic PLC
  • Fresenius Medical Care AG & Co. KGaA
  • Abiomed Inc.
  • Teleflex Incorporated
  • SynCardia Systems
  • CardiacAssist, Inc.
  • Jarvik 2000
  • Reliant Heart
  • Edwards Lifesciences
  • GE Healthcare

These companies are focused on health-based R&D, expansion, and functional ingredient diversification.

Looking for Global, Regional or country-specific reports on this market?

Visit our website or simply fill out the inquiry form, and our team will reach out with customized insights and support - https://www.marknteladvisors.com/query/request-customization/saudi-arabia-lvads-market.html

🧠 Frequently Asked Questions (FAQs)

  1. What are the main drivers of the Saudi Arabia Left Ventricular Assist Devices (LVADs) market?
  2. Which segment leads the Saudi Arabia Left Ventricular Assist Devices (LVADs) industry?
  3. What regulatory challenges impact product development?
  4. Who are the top players in the Saudi Arabia Left Ventricular Assist Devices (LVADs) industry?

About US:

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Us:

MarkNtel Advisors LLP

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511 

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

For Sales Enquiriessales@marknteladvisors.com